Mana.bio Advances AI-Based Lipid Nanoparticle (LNP) Platform to Accelerate Programmable Drug Delivery for RNA and Gene Therapies

/PRNewswire/ -- Mana.bio, a biotechnology company accelerating programmable drug delivery, today unveiled its AI-based lipid nanoparticle (LNP) delivery...

Related Keywords

Israel ,Andreessen Horowitz Bio ,Eitan Kerem ,Kira Radinsky ,Peter Nell ,Omri Amirav Drory ,Robert Langer ,Barry Ticho ,Avi Schroeder ,Roy Nevo ,Yogev Debbi ,Israel Institute Of Chemical Engineers ,Technology Review Young Innovator ,Technion Institute Of Technology ,Pfizer ,Wolf Foundation ,Technion Institute ,Tissue Specific Targeting ,Team Driving Next Wave ,Genome Compiler ,Twist Bioscience ,Chemical Engineering ,Chief Scientist ,Innovator Under ,Stoke Therapeutics ,Chief Medical Officer ,Jordan Green ,Asclepix Therapeutics ,Chronic Diseases ,Guide Therapeutics ,Beam Therapeutics ,General Partner ,Mana Bio ,